2015 American Transplant Congress Archives - Page 18 of 170

5:30pm-7:30pm: Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience

P. Vaitla, U. Patel, A. Cruz, S. Guisti, A. Moiz, C.-S. Catherine, A. Cohen, G. Loss, H. Bohorquez, I. Carmody, T. Reichman, D. Bruce, S. Anders, J. Garces.

Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E

5:30pm-7:30pm: Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience

C. Fasola, P. Mantry, J. Weinstein, H. Nazario, A. Mubarak, M. Barnes, A. Habib, A. Mejia, R. Dickerman, S. Cheng.

Poster Session A: Liver Transplantation: Viral Hepatitis • Exhibit Hall E

5:30pm-7:30pm: Long-Term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation

J. Weiner, J. Zuber, B. Shonts, S. Yang, M. Martinez, T. Kato, M. Sykes.

Poster Session A: Small Bowel All Topics • Exhibit Hall E

5:30pm-7:30pm: Longitudinal Assessment of Endothelial Function Following Kidney Transplantation

C. Kensinger,¹ G. Chen,² A. Bian,² T. Ikizler,³ K. Birdwell.³

Poster Session A: Kidney: Cardiovascular and Metabolic • Exhibit Hall E

5:30pm-7:30pm: Longitudinal eGFR Modelling to Understand Rates of eGFR Decline in Renal Transplantation in the United Kingdom

R. Pruthi,¹ A. Casula,¹ R. Hilton,² R. Ravanan,³ P. Roderick,⁴ I. Macphee.⁵

Poster Session A: Kidney Candidate Issues and Outcomes • Exhibit Hall E

5:30pm-7:30pm: Losartan Benefits Are Mediated Through SIRT1 Activation in Rat Reduced Size Orthotopic Liver Transplantation

E. Pantazi,¹ M. Bejaoui,¹ M. Zaouali,¹ E. Folch-Puy,¹ A. Rolo,^2,3 A. Panisello,¹ C. Palmeira,² J. Rosello-Catafau.¹

Poster Session A: Acute Allograft Rejection • Exhibit Hall E

5:30pm-7:30pm: Low Dose Valganciclovir Is an Effective Prophylaxis Against Cytomegalovirus in High Risk (Donor+/ Recipient-) Kidney Transplants Recipients

S. Fayek,¹ E. Beshears,¹ N. Alvey,² A. Sauer,¹ R. Lieber,¹ O. Olaitan,¹ E. Hollinger,¹ S. Jensik,¹ J. Geyston,² M. Brokhof,² A. Hodowanec,³ D. Simon,³ M. Hertl.¹

Poster Session A: Infection • Exhibit Hall E

5:30pm-7:30pm: Low Expanded Criteria Donor Listing Rates by Organ Procurement Organization Is Associated With Increased Differential in Waiting Time for Candidates Willing to Accept Marginal Organs in the US

D. Keith, A. Nishio Lucar, G. Vranic.

Poster Session A: Kidney Candidate Issues and Outcomes • Exhibit Hall E

5:30pm-7:30pm: Maintaining Immunosuppressive Treatment After Early Allograft Nephrectomy Does Not Reduce the Risk of Anti-HLA Allo-Sensitization

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 I. Cardeau-Desangles,¹ C. Guilbeau-Frugier,^2,5 E. Pambrun,¹ G. Dörr,¹ O. Milioto,⁶ L. Esposito,¹ L. Rostaing,^1,2,7 N. Kamar.^1,2,7

Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis • Exhibit Hall E

5:30pm-7:30pm: Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction

J. Fleming,¹ J. Casale,¹ K. Covert,¹ K. Boyle,¹ D. Taber,² H. Meadows,¹ C. Mardis,¹ N. Pilch,¹ M. Posadas-Salas,³ T. Srinivas,³ C. Bratton,² J. McGillicuddy,² K. Chavin,² P. Baliga.²

Poster Session A: Non Organ Specific, Economics, Public Policy, Allocation, Ethics • Exhibit Hall E